APA (7th ed.) Citation

J, v. d. G., R, W., I, B., D, M., F, R., PJ, W., . . . P, B. (2022). Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer: Predictive Factors for Response and Interim Analysis of the Prospective INVERT-Trial. Frontiers in oncology, 12, 817692. https://doi.org/10.3389/fonc.2022.817692

Chicago Style (17th ed.) Citation

J, von der Grün, et al. "Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer: Predictive Factors for Response and Interim Analysis of the Prospective INVERT-Trial." Frontiers in Oncology 12 (2022): 817692. https://doi.org/10.3389/fonc.2022.817692.

MLA (9th ed.) Citation

J, von der Grün, et al. "Neoadjuvant Chemoradiotherapy for Oral Cavity Cancer: Predictive Factors for Response and Interim Analysis of the Prospective INVERT-Trial." Frontiers in Oncology, vol. 12, 2022, p. 817692, https://doi.org/10.3389/fonc.2022.817692.